Pharmacia says drug gets U.S. approval

Article Abstract:

Pharmacia & Upjohn Inc. announced that its new Vestra antidepressant drug has been given preliminary approval by the US Food and Drug Administration. Vestra is the first selective norepinephrine reuptake inhibitors that increase the amount of nerve signal transmitting chemical in synapses which are located in between brain cells. The drug is known generically as reboxetine.

Comment:

New Vestra antidepressant drug given preliminary approval by US Food and Drug Administration

Product information, Antidepressant Preparations, Laws, regulations and rules, Abstract, Pharmacia and Upjohn Inc., Antidepressants, United States. Food and Drug Administration

---

Merck, Others Plan More Cuts In AIDS-Drug Prices to Africa

Article Abstract:

White House Station, NJ-based Merck and Company Inc. and other major pharmaceutical companies will drastically lower the costs on drugs used to treat persons with HIV/AIDS. The drug makers, which have been heavily criticized by health care organizations and activists, were praised by the World Health Organization.

Consumer prices, Prices and rates, International aspects, World Health Organization, Merck & Company Inc.

---

Bristol-Myers finds spending money is difficult in Africa

Article Abstract:

Bristol-Myers will donate $100 million to fight AIDS in 5 southern Africa nations from 2000-2004. There are several restrictions on the donations which is making it difficult for individuals receiving the funds to spend the funds where the individuals feel there is a need.

Public affairs, Africa, Care and treatment, Statistical Data Included, Public relations, Bristol-Myers Squibb Co., BMY, Southern Africa

Similar abstracts:

• Abstracts: Sears Roebuck beats forecasts as provisions fall. Weak sales force Sears to lower profit forecast. Sears Roebuck posts 61% rise in 1st-quarter net
• Abstracts: Daewoo plans sale of assets. Korean creditors take further action on Daewoo
• Abstracts: Global Crossing will acquire C&W unit. Allianz will take stake in Pimco. Deutsche Telekom Fuels Speculation on Deals. Some Sobering Facts for Holders and Directors

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.